[ET Net News Agency, 10 July 2026] ASCENTAGE (06855) rose 10% to HK$37.4.
It hits an intra-day high of HK$37.4, breaking above the 50-D SMA of HK$37.248, and an intra-day low of HK$33.86. The total shares traded was 1.58 million, with a value of HK$56.3m. The active buy/sell ratio is 68:32, with net buying turnover of HK$19.32m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$895,367, with volume weighted average price of HK$35.086. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$4.1m, with volume weighted average price of HK$35.822.
Basic Information| Nominal | 37.400 | % Chg | +10.00% |
| High | 37.400 | Low | 33.860 |
| Shares Tr | 1.58m | Turnover | 56.3m |
| 10-D SMA | 34.722 | %H.V | 58.399 |
| 20-D SMA | 33.680 | VWAP | 35.723 |
| 50-D SMA | 37.248 | RSI14 | 57.016 |
Status: Breaking above the 50-D SMA, active buy/sell ratio is 68:32, with net buying turnover of HK$19.32m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| ASCENTAGE (06855) | 37.40 | +10.00 |
| INNOVENT BIO (01801) | 90.85 | +5.21 |
| KEYMED BIO-B (02162) | 87.10 | +3.38 |
| WUXI BIO (02269) | 39.40 | +6.31 |
| WUXI APPTEC (02359) | 159.40 | +6.98 |
| PHARMARON (03759) | 22.74 | +12.46 |
| BEONE MEDICINES (06160) | 187.60 | +3.13 |
| SKB BIO (06990) | 508.00 | +6.95 |
| AKESO (09926) | 100.80 | +6.50 |
| REMEGEN (09995) | 88.00 | +7.38 |
(ed)
Nominal 
